Westpac Banking Corp Abbott Laboratories Transaction History

Westpac Banking Corp

  • $1.49 Trillion
  • Q3 2024

A detailed history of Westpac Banking Corp transactions in Abbott Laboratories stock. As of the latest transaction made, Westpac Banking Corp holds 15,881 shares of ABT stock, worth $1.8 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares
15,881
Previous 14,840 7.01%
Holding current value
$1.8 Million
Previous $1.54 Billion 17.42%
% of portfolio
0.12%
Previous 0.12%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024
BUY
$100.07 - $118.13 $104,172 - $122,973
1,041 Added 7.01%
15,881 $1.81 Billion
Q2 2024

Aug 14, 2024
BUY
$100.73 - $112.44 $1.48 Million - $1.66 Million
14,736 Added 14169.23%
14,840 $1.54 Billion
Q2 2024

Aug 12, 2024
SELL
$100.73 - $112.44 $1.36 Million - $1.52 Million
-13,530 Reduced 99.24%
104 $1.54 Billion
Q1 2024

May 09, 2024
SELL
$109.52 - $120.96 $19,056 - $21,047
-174 Reduced 1.26%
13,634 $1.55 Billion
Q4 2023

Feb 08, 2024
SELL
$90.19 - $110.4 $790,876 - $968,097
-8,769 Reduced 38.84%
13,808 $1.52 Billion
Q3 2023

Nov 09, 2023
SELL
$95.53 - $114.62 $3.12 Million - $3.74 Million
-32,623 Reduced 59.1%
22,577 $2.19 Billion
Q2 2023

Aug 10, 2023
SELL
$100.78 - $112.29 $18.8 Million - $21 Million
-186,948 Reduced 77.2%
55,200 $6.02 Billion
Q1 2023

May 03, 2023
SELL
$96.86 - $114.01 $8.74 Million - $10.3 Million
-90,206 Reduced 27.14%
242,148 $24.5 Billion
Q4 2022

Feb 06, 2023
BUY
$95.06 - $111.52 $2.23 Million - $2.62 Million
23,460 Added 7.59%
332,354 $36.5 Billion
Q3 2022

Nov 08, 2022
BUY
$96.76 - $112.03 $2.56 Million - $2.96 Million
26,431 Added 9.36%
308,894 $29.9 Billion
Q2 2022

Aug 10, 2022
BUY
$102.07 - $123.37 $397,154 - $480,032
3,891 Added 1.4%
282,463 $30.7 Billion
Q1 2022

May 11, 2022
SELL
$114.02 - $139.04 $740,901 - $903,481
-6,498 Reduced 2.28%
278,572 $33 Million
Q4 2021

Feb 08, 2022
BUY
$115.53 - $141.46 $6 Million - $7.35 Million
51,947 Added 22.28%
285,070 $40.1 Billion
Q3 2021

Oct 27, 2021
SELL
$116.66 - $129.06 $1.95 Million - $2.15 Million
-16,682 Reduced 6.68%
233,123 $27.5 Million
Q2 2021

Aug 11, 2021
SELL
$105.79 - $124.53 $4.58 Million - $5.39 Million
-43,292 Reduced 14.77%
249,805 $29 Million
Q4 2020

Feb 11, 2021
BUY
$105.0 - $114.42 $979,125 - $1.07 Million
9,325 Added 3.29%
293,097 $32.1 Million
Q3 2020

Nov 10, 2020
BUY
$91.64 - $111.29 $261,448 - $317,510
2,853 Added 1.02%
283,772 $30.9 Million
Q2 2020

Aug 12, 2020
SELL
$76.57 - $98.0 $4.53 Million - $5.8 Million
-59,170 Reduced 17.4%
280,919 $25.7 Million
Q1 2020

May 14, 2020
SELL
$62.82 - $91.86 $146,119 - $213,666
-2,326 Reduced 0.68%
340,089 $26.8 Million
Q4 2019

Feb 11, 2020
SELL
$78.51 - $87.4 $412,727 - $459,461
-5,257 Reduced 1.51%
342,415 $29.7 Million
Q3 2019

Nov 13, 2019
SELL
$81.84 - $88.74 $358,786 - $389,036
-4,384 Reduced 1.25%
347,672 $29.1 Million
Q2 2019

Aug 01, 2019
BUY
$72.88 - $85.0 $706,425 - $823,905
9,693 Added 2.83%
352,056 $0
Q1 2019

May 14, 2019
SELL
$66.22 - $80.06 $13.9 Million - $16.8 Million
-209,527 Reduced 37.97%
342,363 $0
Q4 2018

Feb 07, 2019
SELL
$65.56 - $74.27 $1.47 Million - $1.67 Million
-22,449 Reduced 3.91%
551,890 $39.9 Million
Q3 2018

Nov 13, 2018
BUY
$60.81 - $73.36 $1.35 Million - $1.63 Million
22,152 Added 4.01%
574,339 $0
Q2 2018

Jul 18, 2018
SELL
$57.57 - $63.54 $356,703 - $393,693
-6,196 Reduced 1.11%
552,187 $0
Q1 2018

May 01, 2018
BUY
$56.27 - $63.62 $2.59 Million - $2.93 Million
46,081 Added 8.99%
558,383 $0
Q4 2017

Jan 18, 2018
SELL
$53.68 - $57.47 $301,144 - $322,406
-5,610 Reduced 1.08%
512,302 $0
Q3 2017

Oct 30, 2017
BUY
$48.06 - $53.64 $24.9 Million - $27.8 Million
517,912
517,912 $0

Others Institutions Holding ABT

# of Institutions
3,186
Shares Held
1.3B
Call Options Held
8.74M
Put Options Held
8.08M
View Full List

About ABBOTT LABORATORIES

ABT Quotes by TradingView
  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $198B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Westpac Banking Corp Portfolio

Follow Westpac Banking Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Westpac Banking Corp, based on Form 13F filings with the SEC.

News

Stay updated on Westpac Banking Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email